Filter
702
Filtered Results: 702
Text search:
FDA
Featured
Recommendations
93
New Publications
138
Language
Document type
No document type
337
Guidelines
191
Studies & Reports
88
Manuals
27
Fact sheets
25
Strategic & Response Plan
15
Training Material
9
Resource Platforms
3
Infographics
3
Brochures
2
Situation Updates
2
Countries / Regions
India
40
Latin America and the Carribbean
21
Ghana
19
Russia
17
Philippines
15
Germany
12
Brazil
12
Myanmar / Burma
12
Global
11
Congo, Democratic Republic of
11
South Africa
10
Middle East and North Africa
9
Kenya
8
USA
8
West and Central Africa
8
Syria
7
Nigeria
7
Argentina
7
Ecuador
7
Colombia
6
Ukraine
6
Senegal
6
Western and Central Europe
6
Uganda
6
Yemen
6
Angola
6
Nepal
5
Sierra Leone
5
Mozambique
5
Paraguay
5
Eastern Europe
5
Ethiopia
5
South Sudan
5
Indonesia
5
Thailand
4
Burkina Faso
4
Peru
4
Eastern Europe and Central Asia
4
France
4
East and Southern Africa
4
Sudan
4
Mali
4
Liberia
4
Benin
3
Rwanda
3
Chile
3
Guinea
3
Africa
3
Venezuela
3
Tanzania
3
South–East Asia Region
3
Spain
3
Bolivia
3
Bangladesh
3
Tajikistan
2
El Salvador
2
Albania
2
Niger
2
Haiti
2
Asia
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Namibia
2
Iraq
2
Mexico
1
Turkey
1
Kazakhstan
1
Cameroon
1
Singapore
1
Congo-Brazzaville
1
Malawi
1
Zimbabwe
1
Morocco
1
Qatar
1
Mauritania
1
Armenia
1
Cambodia
1
Dominican Republic
1
Tunisia
1
United Kingdom
1
Belarus
1
Israel
1
Lebanon
1
Nicaragua
1
Moldova
1
Egypt
1
Honduras
1
Chad
1
Libya
1
Botswana
1
Somalia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
227
Clinical Guidelines
85
Pharmacy & Technologies
23
Women & Child Health
20
Public Health
14
Key Resources
9
Capacity Building
5
Toolboxes
COVID-19
159
Mental Health
69
TB
63
HIV
53
Pharmacy
39
AMR
36
Ebola
31
Rapid Response
20
Specific Hazards
13
NTDs
11
Planetary Health
10
NCDs
10
Zika
9
Refugee
7
Cholera
5
Natural Hazards
4
Caregiver
4
Conflict
3
Global Health Education
3
Disability
1
Health Financing Toolbox
1
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Guía de medicamentos esenciales para primer nivel de atención – Edición 2019
Las guías para la prevención de Infecciones del Sitio Quirúrgico (ISQ) resumen las medidas basadas en la evidencia que han demostrado disminuir su incidencia y mejorar la calidad asistencial de los pacientes sometidos a cirugía. La última revisión local fue realizada en el año 2009, en el mar...
Accessed on 16.08.2022
Para ello integra:
• Las 36 recomendaciones sobre diabetes mellitus tipo 2:
1. Rastreo y diagnóstico.
2. Prevención.
3. Educación diabetológica para el automanejo.
4. Metas de control glucémico.
5. Tratamiento: estilo de vida saludable y tratamiento farmacoló...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Traitements contre la maladie à virus Ebola
recommended
Cette première version des orientations evolutives relatives a la prise en charge clinique de la MVE contient quatre nouvelles recommandations concernant l’utilisation de traitements contre la MVE, y compris deux recommandations fortes en faveur de l’utilisation de thérapies à base d’antico...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Ce rapport présente une analyse de l'OMS sur les pénuries et le manque de disponibilité des antibiotiques hors brevet en France prenant en compte l'approche Une seule santé. Le rapport est organisé en deux sections : santé animale et santé humaine.
Le rapport vise à donner un éclairage sur...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
